Bank of America Corp Reports New 5.1% Passive Stake in MacroGenics Inc (MGNX)

2026-05-14SEC Filing SCHEDULE 13G (0000070858-26-000308)

On May 14, 2026, Bank of America Corporation filed a Schedule 13G with the SEC, disclosing a new 5.1% ownership stake in MacroGenics, Inc. (MGNX). As of the event date of March 31, 2026, the filer beneficially owns 3,258,574 shares of common stock. This position was established from a previous holding of zero shares, marking a significant entry into the issuer's equity. The filing was submitted on behalf of Bank of America and its wholly-owned subsidiaries, including BofA Securities, Inc., Bank of America N.A., and Merrill Lynch International. The reported ownership calculation is based on 63,560,068 outstanding shares. Bank of America reported shared voting and dispositive power over the full amount of shares. The filing includes a certification that the securities were acquired in the ordinary course of business and are not held for the purpose of changing or influencing the control of the issuer, characterizing this as a passive investment.

Ticker mentioned:MGNXInstitution mentioned:BANK OF AMERICA CORP /DE/
Related industry:Biotechnology